The studies by Karlsen et al. 22 and Gaj et al. 23 did not show an impact of NOD2 variants on the development of primary sclerosing cholangitis (PSC) or primary biliary cholangitis (PBC), respectively. Here, NOD2 is linked to pancreatic serous cystadenoma.